130 related articles for article (PubMed ID: 16279780)
1. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
Gangjee A; Lin X; Kisliuk RL; McGuire JJ
J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
[TBL] [Abstract][Full Text] [Related]
2. 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.
Gangjee A; Jain HD; Phan J; Guo X; Queener SF; Kisliuk RL
Bioorg Med Chem; 2010 Jan; 18(2):953-61. PubMed ID: 20056546
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a classical 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine as antifolates.
Gangjee A; Yang J; McGuire JJ; Kisliuk RL
Bioorg Med Chem; 2006 Dec; 14(24):8590-8. PubMed ID: 16990006
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.
Zhang X; Zhou X; Kisliuk RL; Piraino J; Cody V; Gangjee A
Bioorg Med Chem; 2011 Jun; 19(11):3585-94. PubMed ID: 21550809
[TBL] [Abstract][Full Text] [Related]
5. Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase.
Kumar VP; Cisneros JA; Frey KM; Castellanos-Gonzalez A; Wang Y; Gangjee A; White AC; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2014 Sep; 24(17):4158-61. PubMed ID: 25127103
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity correlations for three pyrido[2,3-d]pyrimidine antifolates binding to human and Pneumocystis carinii dihydrofolate reductase.
Cody V; Pace J; Namjoshi OA; Gangjee A
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):799-803. PubMed ID: 26057816
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma brucei DHFR-TS Revisited: Characterisation of a Bifunctional and Highly Unstable Recombinant Dihydrofolate Reductase-Thymidylate Synthase.
Gibson MW; Dewar S; Ong HB; Sienkiewicz N; Fairlamb AH
PLoS Negl Trop Dis; 2016 May; 10(5):e0004714. PubMed ID: 27175479
[TBL] [Abstract][Full Text] [Related]
8. An innovative strategy for dual inhibitor design and its application in dual inhibition of human thymidylate synthase and dihydrofolate reductase enzymes.
Arooj M; Sakkiah S; Cao Gp; Lee KW
PLoS One; 2013; 8(4):e60470. PubMed ID: 23577115
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis.
Nammalwar B; Bunce RA; Berlin KD; Bourne CR; Bourne PC; Barrow EW; Barrow WW
Eur J Med Chem; 2012 Aug; 54():387-96. PubMed ID: 22703705
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 5-(arylthio)-9H-pyrimido[4,5-b]indole-2,4-diamines as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.
Zaware N; Kisliuk R; Bastian A; Ihnat MA; Gangjee A
Bioorg Med Chem Lett; 2017 Apr; 27(7):1602-1607. PubMed ID: 28258797
[TBL] [Abstract][Full Text] [Related]
11. Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance.
Anderson AC
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Mar; 61(Pt 3):258-62. PubMed ID: 16511011
[TBL] [Abstract][Full Text] [Related]
12. In vitro biological activity and structural analysis of 2,4-diamino-5-(2'-arylpropargyl)pyrimidine inhibitors of Candida albicans.
Paulsen JL; Liu J; Bolstad DB; Smith AE; Priestley ND; Wright DL; Anderson AC
Bioorg Med Chem; 2009 Jul; 17(14):4866-72. PubMed ID: 19560363
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.
Gangjee A; Li W; Lin L; Zeng Y; Ihnat M; Warnke LA; Green DW; Cody V; Pace J; Queener SF
Bioorg Med Chem; 2009 Oct; 17(20):7324-36. PubMed ID: 19748785
[TBL] [Abstract][Full Text] [Related]
14. Structural and Biological Investigations for a Series of N-5 Substituted Pyrrolo[3,2-
Cawrse BM; Robinson NM; Lee NC; Wilson GM; Seley-Radtke KL
Molecules; 2019 Jul; 24(14):. PubMed ID: 31340431
[TBL] [Abstract][Full Text] [Related]
15. The 3-D conformational shape of N-naphthyl-cyclopenta[d]pyrimidines affects their potency as microtubule targeting agents and their antitumor activity.
Xiang W; Quadery TM; Hamel E; Luckett-Chastain LR; Ihnat MA; Mooberry SL; Gangjee A
Bioorg Med Chem; 2021 Jan; 29():115887. PubMed ID: 33310545
[TBL] [Abstract][Full Text] [Related]
16. The Z isomer of 2,4-diaminofuro[2,3-d]pyrimidine antifolate promotes unusual crystal packing in a human dihydrofolate reductase ternary complex.
Cody V; Pace J; Lin L; Gangjee A
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Aug; 65(Pt 8):762-6. PubMed ID: 19652333
[TBL] [Abstract][Full Text] [Related]
17. 2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance.
Gangjee A; Namjoshi OA; Keller SN; Smith CD
Bioorg Med Chem; 2011 Jul; 19(14):4355-65. PubMed ID: 21680190
[TBL] [Abstract][Full Text] [Related]
18. Exploration and Biological Evaluation of 1,3-Diamino-7
Zhu Z; Chen C; Zhang J; Lai F; Feng J; Wu G; Xia J; Zhang W; Han Z; Zhang C; Yang Q; Wang Y; Liu B; Li T; Wu S
J Med Chem; 2023 Oct; 66(20):13946-13967. PubMed ID: 37698518
[TBL] [Abstract][Full Text] [Related]
19. Targeting the TS dimer interface in bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa: Virtual screening identifies novel TS allosteric inhibitors.
Ruiz VG; Czyzyk DJ; Kumar VP; Jorgensen WL; Anderson KS
Bioorg Med Chem Lett; 2020 Aug; 30(16):127292. PubMed ID: 32631514
[TBL] [Abstract][Full Text] [Related]
20. A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium.
Mukerjee A; Iyidogan P; Castellanos-Gonzalez A; Cisneros JA; Czyzyk D; Ranjan AP; Jorgensen WL; White AC; Vishwanatha JK; Anderson KS
Bioorg Med Chem Lett; 2015; 25(10):2065-7. PubMed ID: 25900220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
